NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 23, 2026 /PRNewswire/ -- The New York...
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 23, 2026 /PRNewswire/ -- The New York...
To kickoff the launch of the campaign, Rula will offer free "3am Therapy" sessions to provide support when people need...
TAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced...
DUBLIN--(BUSINESS WIRE)--$PRTA #Prothena--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on...
Cambridge, Massachusetts, March 18, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies...
New integrative mental health program combines neuroscience, personalized assessments, and evidence-based psychiatric care to help individuals restore energy, resilience, and...
WATERTOWN, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics...
Award-winning actress Jane Lynch, AI pioneer Dr. Rana el Kaliouby, and NBA champion J.R. Smith joined global experts to explore...
Fresh Tri's neuroscience-based platform delivers superior long-term weight loss and retention against gold-standard behavior change programFELTON, Calif., March 12, 2026...
PHOENIX, March 12, 2026 /PRNewswire/ -- Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading international alternative asset manager, today...
BURLINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the...
SAN DIEGO, March 11, 2026 /PRNewswire/ -- Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers...
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'GALWAY, Ireland, March 10, 2026 /PRNewswire/ -- Medtronic...
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'GALWAY, Ireland, March 10, 2026 /PRNewswire/ -- Medtronic...
Deal complements Medtronic's Neurovascular portfolio, delivering simplicity and access when 'time is brain'GALWAY, Ireland, March 10, 2026 /PRNewswire/ -- Medtronic...
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company),...
SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect, or the Company),...
RAP-219’s lead program demonstrated robust and consistent activity in patients with focal onset seizures (FOS) in Phase 2a trial; initiation...
CLEARWATER, Fla. and MORGANTOWN, W.Va., March 9, 2026 /PRNewswire/ -- WVU Health System, the clinical and academic health enterprise of...
Dr. Robert Lenz brings over 20 years of experience in neuroscience drug developmentNEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --...